Control of neural circuit formation by leucine-rich repeat proteins

Trends in Neurosciences

Volumn 37, Issue 10, 2014, Pages 539-550

  de Wit, Joris ^a,c   Ghosh, Anirvan ^b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Connectivity; Excitation inhibition balance; Glutamate receptor; Synaptic adhesion; Synaptic transmission; Synaptogenesis

Indexed keywords

FIBRONECTIN; G PROTEIN COUPLED RECEPTOR; LATROPHILIN; LEUCINE RICH REPEAT PROTEIN; MEMBRANE PROTEIN; NETRIN G; RECEPTOR PROTEIN; SLIT PROTEIN; UNCLASSIFIED DRUG; LEUCINE-RICH REPEAT PROTEINS; PROTEIN;

DEGENERATIVE DISEASE; EXCITATORY POSTSYNAPTIC POTENTIAL; MENTAL DISEASE; NERVE CELL MEMBRANE POTENTIAL; NERVE CELL PLASTICITY; PRESYNAPTIC POTENTIAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; ANIMAL; HUMAN; METABOLISM; NERVE TRACT; PHYSIOLOGY; SYNAPSE; SYNAPTIC TRANSMISSION;

ANIMALS; HUMANS; NEURAL PATHWAYS; PROTEINS; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84912571110     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2014.07.004     Document Type: Review

References (124)

1. Tabuchi K., et al. A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 2007, 318:71-76.
2. Etherton M., et al. Autism-linked neuroligin-3 R451C mutation differentially alters hippocampal and cortical synaptic function. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:13764-13769.
3. Baudouin S.J., et al. Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism. Science 2012, 338:128-132.
4. Etherton M.R., et al. Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:17998-18003.
5. Schmeisser M.J., et al. Autistic-like behaviours and hyperactivity in mice lacking ProSAP1/Shank2. Nature 2012, 486:256-260.
6. Peca J., et al. Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 2011, 472:437-442.
7. Jamain S., et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 2003, 34:27-29.
8. Penagarikano O., et al. Absence of CNTNAP2 leads to epilepsy, neuronal migration abnormalities, and core autism-related deficits. Cell 2011, 147:235-246.
9. Dolan J., et al. The extracellular leucine-rich repeat superfamily; a comparative survey and analysis of evolutionary relationships and expression patterns. BMC Genomics 2007, 8:320.
10. Biederer T., Scheiffele P. Mixed-culture assays for analyzing neuronal synapse formation. Nat. Protoc. 2007, 2:670-676.
11. Scheiffele P., et al. Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 2000, 101:657-669.
12. Linhoff M.W., et al. An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizers. Neuron 2009, 61:734-749.
13. Lauren J., et al. A novel gene family encoding leucine-rich repeat transmembrane proteins differentially expressed in the nervous system. Genomics 2003, 81:411-421.
14. de Wit J., et al. LRRTM2 interacts with Neurexin1 and regulates excitatory synapse formation. Neuron 2009, 64:799-806.
15. Ko J., et al. LRRTM2 functions as a neurexin ligand in promoting excitatory synapse formation. Neuron 2009, 64:791-798.
16. Siddiqui T.J., et al. LRRTMs and neuroligins bind neurexins with a differential code to cooperate in glutamate synapse development. J. Neurosci. 2010, 30:7495-7506.
17. Sudhof T.C. Neuroligins and neurexins link synaptic function to cognitive disease. Nature 2008, 455:903-911.
18. Baudouin S., Scheiffele P. SnapShot: Neuroligin-neurexin complexes. Cell 2010, 141:908. 908 e901.
19. Ichtchenko K., et al. Neuroligin 1: a splice site-specific ligand for beta-neurexins. Cell 1995, 81:435-443.
20. Uemura T., et al. Trans-synaptic interaction of GluRdelta2 and Neurexin through Cbln1 mediates synapse formation in the cerebellum. Cell 2010, 141:1068-1079.
21. Krueger D.D., et al. The role of neurexins and neuroligins in the formation, maturation, and function of vertebrate synapses. Curr. Opin. Neurobiol. 2012, 22:412-422.
22. de Wit J., et al. Unbiased discovery of glypican as a receptor for LRRTM4 in regulating excitatory synapse development. Neuron 2013, 79:696-711.
23. Siddiqui T.J., et al. An LRRTM4-HSPG complex mediates excitatory synapse development on dentate gyrus granule cells. Neuron 2013, 79:680-695.
24. Johnson K.G., et al. The HSPGs Syndecan and Dallylike bind the receptor phosphatase LAR and exert distinct effects on synaptic development. Neuron 2006, 49:517-531.
25. Ko J., et al. Neuroligins/LRRTMs prevent activity- and Ca2+/calmodulin-dependent synapse elimination in cultured neurons. J. Cell Biol. 2011, 194:323-334.
26. Takashima N., et al. Impaired cognitive function and altered hippocampal synapse morphology in mice lacking Lrrtm1, a gene associated with schizophrenia. PLoS ONE 2011, 6:e22716.
27. Soler-Llavina G.J., et al. The neurexin ligands, neuroligins and leucine-rich repeat transmembrane proteins, perform convergent and divergent synaptic functions in vivo. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:16502-16509.
28. Takahashi H., et al. Selective control of inhibitory synapse development by Slitrk3-PTPdelta trans-synaptic interaction. Nat. Neurosci. 2012, 15:389-398. S381-382.
29. Yim Y.S., et al. Slitrks control excitatory and inhibitory synapse formation with LAR receptor protein tyrosine phosphatases. Proc. Natl. Acad. Sci. U.S.A. 2013, 110:4057-4062.
30. Shmelkov S.V., et al. Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice. Nat. Med. 2010, 16:598-602. 591p following 602.
31. Tekin M., et al. SLITRK6 mutations cause myopia and deafness in humans and mice. J. Clin. Invest. 2013, 123:2094-2102.
32. Takahashi H., et al. Postsynaptic TrkC and presynaptic PTPsigma function as a bidirectional excitatory synaptic organizing complex. Neuron 2011, 69:287-303.
33. Woo J., et al. Trans-synaptic adhesion between NGL-3 and LAR regulates the formation of excitatory synapses. Nat. Neurosci. 2009, 12:428-437.
34. Yoshida T., et al. IL-1 receptor accessory protein-like 1 associated with mental retardation and autism mediates synapse formation by trans-synaptic interaction with protein tyrosine phosphatase delta. J. Neurosci. 2011, 31:13485-13499.
35. Yoshida T., et al. Interleukin-1 receptor accessory protein organizes neuronal synaptogenesis as a cell adhesion molecule. J. Neurosci. 2012, 32:2588-2600.
36. Valnegri P., et al. The X-linked intellectual disability protein IL1RAPL1 regulates excitatory synapse formation by binding PTPdelta and RhoGAP2. Hum. Mol. Genet. 2011, 20:4797-4809.
37. Takahashi H., Craig A.M. Protein tyrosine phosphatases PTPdelta, PTPsigma, and LAR: presynaptic hubs for synapse organization. Trends Neurosci. 2013, 36:522-534.
38. Kajiwara Y., et al. SLITRK1 binds 14-3-3 and regulates neurite outgrowth in a phosphorylation-dependent manner. Biol. Psychiatry 2009, 66:918-925.
39. Kim S., et al. NGL family PSD-95-interacting adhesion molecules regulate excitatory synapse formation. Nat. Neurosci. 2006, 9:1294-1301.
40. Kwon S.K., et al. Trans-synaptic adhesions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases LAR, protein-tyrosine phosphatase delta (PTPdelta), and PTPsigma via specific domains regulate excitatory synapse formation. J. Biol. Chem. 2010, 285:13966-13978.
41. Nishimura-Akiyoshi S., et al. Axonal netrin-Gs transneuronally determine lamina-specific subdendritic segments. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:14801-14806.
42. Lin J.C., et al. The netrin-G1 ligand NGL-1 promotes the outgrowth of thalamocortical axons. Nat. Neurosci. 2003, 6:1270-1276.
43. Song Y.S., et al. Trans-induced cis interaction in the tripartite NGL-1, netrin-G1 and LAR adhesion complex promotes development of excitatory synapses. J. Cell Sci. 2013, 126:4926-4938.
44. Yin Y., et al. Laminets: laminin- and netrin-related genes expressed in distinct neuronal subsets. Mol. Cell. Neurosci. 2002, 19:344-358.
45. Nakashiba T., et al. Netrin-G1: a novel glycosyl phosphatidylinositol-linked mammalian netrin that is functionally divergent from classical netrins. J. Neurosci. 2000, 20:6540-6550.
46. Meerabux J.M., et al. Human netrin-G1 isoforms show evidence of differential expression. Genomics 2005, 86:112-116.
47. Brasch J., et al. Crystal structure of the ligand binding domain of netrin G2. J. Mol. Biol. 2011, 414:723-734.
48. Nakashiba T., et al. Complementary expression and neurite outgrowth activity of netrin-G subfamily members. Mech. Dev. 2002, 111:47-60.
49. DeNardo L.A., et al. NGL-2 regulates input-specific synapse development in CA1 pyramidal neurons. Neuron 2012, 76:762-775.
50. Soto F., et al. NGL-2 regulates pathway-specific neurite growth and lamination, synapse formation, and signal transmission in the retina. J. Neurosci. 2013, 33:11949-11959.
51. Ricciardi S., et al. CDKL5 ensures excitatory synapse stability by reinforcing NGL-1-PSD95 interaction in the postsynaptic compartment and is impaired in patient iPSC-derived neurons. Nat. Cell Biol. 2012, 14:911-923.
52. O'Sullivan M.L., et al. FLRT Proteins Are Endogenous Latrophilin Ligands and Regulate Excitatory Synapse Development. Neuron 2012, 73:903-910.
53. Langenhan T., et al. Sticky signaling--adhesion class G protein-coupled receptors take the stage. Sci. Signal. 2013, 6:re3.
54. Silva J.P., Ushkaryov Y.A. The latrophilins, 'split-personality' receptors. Adv. Exp. Med. Biol. 2010, 706:59-75.
55. Ushkaryov Y.A., et al. Neurexins: synaptic cell surface proteins related to the alpha-latrotoxin receptor and laminin. Science 1992, 257:50-56.
56. Krasnoperov V.G., et al. alpha-Latrotoxin stimulates exocytosis by the interaction with a neuronal G-protein-coupled receptor. Neuron 1997, 18:925-937.
57. Davletov B.A., et al. Isolation and biochemical characterization of a Ca2+-independent alpha-latrotoxin-binding protein. J. Biol. Chem. 1996, 271:23239-23245.
58. Sugita S., et al. alpha-Latrotoxin receptor CIRL/latrophilin 1 (CL1) defines an unusual family of ubiquitous G-protein-linked receptors. G-protein coupling not required for triggering exocytosis. J. Biol. Chem. 1998, 273:32715-32724.
59. Krasnoperov V.G., et al. The calcium-independent receptor of alpha-latrotoxin is not a neurexin. Biochem. Biophys. Res. Commun. 1996, 227:868-875.
60. Silva J.P., et al. Latrophilin 1 and its endogenous ligand Lasso/teneurin-2 form a high-affinity transsynaptic receptor pair with signaling capabilities. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:12113-12118.
61. Boucard A.A., et al. Latrophilins function as heterophilic cell-adhesion molecules by binding to teneurins: regulation by alternative splicing. J. Biol. Chem. 2014, 289:387-402.
62. Mosca T.J., et al. Trans-synaptic Teneurin signalling in neuromuscular synapse organization and target choice. Nature 2012, 484:237-241.
63. Hong W., et al. Teneurins instruct synaptic partner matching in an olfactory map. Nature 2012, 484:201-207.
64. Antinucci P., et al. Teneurin-3 specifies morphological and functional connectivity of retinal ganglion cells in the vertebrate visual system. Cell Rep. 2013, 5:582-592.
65. O'Sullivan M.L., et al. LPHN3, a presynaptic adhesion-GPCR implicated in ADHD, regulates the strength of neocortical layer 2/3 synaptic input to layer 5. Neural Dev. 2014, 9:7.
66. Boucard A.A., et al. High affinity neurexin binding to cell adhesion G-protein-coupled receptor CIRL1/latrophilin-1 produces an intercellular adhesion complex. J. Biol. Chem. 2012, 287:9399-9413.
67. Bottcher R.T., et al. The transmembrane protein XFLRT3 forms a complex with FGF receptors and promotes FGF signalling. Nat. Cell Biol. 2004, 6:38-44.
68. Haines B.P., et al. Regulated expression of FLRT genes implies a functional role in the regulation of FGF signalling during mouse development. Dev. Biol. 2006, 297:14-25.
69. Wheldon L.M., et al. Critical role of FLRT1 phosphorylation in the interdependent regulation of FLRT1 function and FGF receptor signalling. PLoS ONE 2010, 5:e10264.
70. Ogata S., et al. TGF-beta signaling-mediated morphogenesis: modulation of cell adhesion via cadherin endocytosis. Genes Dev. 2007, 21:1817-1831.
71. Chen X., et al. A protocadherin-cadherin-FLRT3 complex controls cell adhesion and morphogenesis. PLoS ONE 2009, 4:e8411.
72. Karaulanov E., et al. Unc5B interacts with FLRT3 and Rnd1 to modulate cell adhesion in Xenopus embryos. PLoS ONE 2009, 4:e5742.
73. Leyva-Diaz E., et al. FLRT3 Is a Robo1-Interacting Protein that Determines Netrin-1 Attraction in Developing Axons. Curr. Biol. 2014, 24:494-508.
74. Yamagishi S., et al. FLRT2 and FLRT3 act as repulsive guidance cues for Unc5-positive neurons. EMBO J. 2011, 30:2920-2933.
75. Huang E.J., Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 2001, 24:677-736.
76. Ko J., et al. SALM synaptic cell adhesion-like molecules regulate the differentiation of excitatory synapses. Neuron 2006, 50:233-245.
77. Wang C.Y., et al. A novel family of adhesion-like molecules that interacts with the NMDA receptor. J. Neurosci. 2006, 26:2174-2183.
78. Morimura N., et al. Comparative analysis of structure, expression and PSD95-binding capacity of Lrfn, a novel family of neuronal transmembrane proteins. Gene 2006, 380:72-83.
79. Mah W., et al. Selected SALM (synaptic adhesion-like molecule) family proteins regulate synapse formation. J. Neurosci. 2010, 30:5559-5568.
80. Seabold G.K., et al. The SALM family of adhesion-like molecules forms heteromeric and homomeric complexes. J. Biol. Chem. 2008, 283:8395-8405.
81. Sylwestrak E.L., Ghosh A. Elfn1 regulates target-specific release probability at CA1-interneuron synapses. Science 2012, 338:536-540.
82. Soler-Llavina G.J., et al. Leucine-rich repeat transmembrane proteins are essential for maintenance of long-term potentiation. Neuron 2013, 79:439-446.
83. Schwenk J., et al. High-resolution proteomics unravel architecture and molecular diversity of native AMPA receptor complexes. Neuron 2012, 74:621-633.
84. de Wit J., et al. Role of leucine-rich repeat proteins in the development and function of neural circuits. Annu. Rev. Cell Dev. Biol. 2011, 27:697-729.
85. Megias M., et al. Total number and distribution of inhibitory and excitatory synapses on hippocampal CA1 pyramidal cells. Neuroscience 2001, 102:527-540.
86. Lein E.S., et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 2007, 445:168-176.
87. Bena F., et al. Molecular and clinical characterization of 25 individuals with exonic deletions of NRXN1 and comprehensive review of the literature. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2013, 162B:388-403.
88. Borg I., et al. Disruption of Netrin G1 by a balanced chromosome translocation in a girl with Rett syndrome. Eur. J. Hum. Genet. 2005, 13:921-927.
89. Aoki-Suzuki M., et al. A family-based association study and gene expression analyses of netrin-G1 and -G2 genes in schizophrenia. Biol. Psychiatry 2005, 57:382-393.
90. Eastwood S.L., Harrison P.J. Decreased mRNA expression of netrin-G1 and netrin-G2 in the temporal lobe in schizophrenia and bipolar disorder. Neuropsychopharmacology 2008, 33:933-945.
91. Domene S., et al. Screening of human LPHN3 for variants with a potential impact on ADHD susceptibility. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2011, 156B:11-18.
92. Francks C., et al. LRRTM1 on chromosome 2p12 is a maternally suppressed gene that is associated paternally with handedness and schizophrenia. Mol. Psychiatry 2007, 12:1129-1139. 1057.
93. Ludwig K.U., et al. Supporting evidence for LRRTM1 imprinting effects in schizophrenia. Mol. Psychiatry 2009, 14:743-745.
94. Leach E.L., et al. The imprinted gene LRRTM1 mediates schizotypy and handedness in a nonclinical population. J. Hum. Genet. 2014, 59:332-336.
95. Malhotra D., et al. High frequencies of de novo CNVs in bipolar disorder and schizophrenia. Neuron 2011, 72:951-963.
96. Kleffmann W., et al. 5q31 Microdeletions: Definition of a Critical Region and Analysis of LRRTM2, a Candidate Gene for Intellectual Disability. Mol. Syndromol. 2012, 3:68-75.
97. Majercak J., et al. LRRTM3 promotes processing of amyloid-precursor protein by BACE1 and is a positional candidate gene for late-onset Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:17967-17972.
98. Liang X., et al. Effect of heterogeneity on the chromosome 10 risk in late-onset Alzheimer disease. Hum. Mutat. 2007, 28:1065-1073.
99. Martin E.R., et al. Interaction between the alpha-T catenin gene (VR22) and APOE in Alzheimer's disease. J. Med. Genet. 2005, 42:787-792.
100. Thornton-Wells T.A., et al. Confronting complexity in late-onset Alzheimer disease: application of two-stage analysis approach addressing heterogeneity and epistasis. Genet. Epidemiol. 2008, 32:187-203.
101. Li H., et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. Arch. Neurol. 2008, 65:45-53.
102. Edwards T.L., et al. An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 2009, 150B:721-735.
103. Reitz C., et al. Effect of genetic variation in LRRTM3 on risk of Alzheimer disease. Arch. Neurol. 2012, 69:894-900.
104. Lincoln S., et al. LRRTM3 interacts with APP and BACE1 and has variants associating with late-onset Alzheimer's disease (LOAD). PLoS ONE 2013, 8:e64164.
105. Wang J., et al. Association of LRRTM3 polymorphisms with late-onset Alzheimer's disease in Han Chinese. Exp. Gerontol. 2014, 52:18-22.
106. Sousa I., et al. Polymorphisms in leucine-rich repeat genes are associated with autism spectrum disorder susceptibility in populations of European ancestry. Mol. Autism 2010, 1:7.
107. Michaelson J.J., et al. Whole-genome sequencing in autism identifies hot spots for de novo germline mutation. Cell 2012, 151:1431-1442.
108. Autism Genome Project C., et al. Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat. Genet. 2007, 39:319-328.
109. Sanders S.J., et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron 2011, 70:863-885.
110. Hussman J.P., et al. A noise-reduction GWAS analysis implicates altered regulation of neurite outgrowth and guidance in autism. Mol. Autism 2011, 2:1.
111. Pinto D., et al. Functional impact of global rare copy number variation in autism spectrum disorders. Nature 2010, 466:368-372.
112. Sebat J., et al. Strong association of de novo copy number mutations with autism. Science 2007, 316:445-449.
113. McQuillin A., et al. Analysis of genetic deletions and duplications in the University College London bipolar disorder case control sample. Eur. J. Hum. Genet. 2011, 19:588-592.
114. O'Roak B.J., et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 2012, 338:1619-1622.
115. O'Roak B.J., et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012, 485:246-250.
116. Fukasawa M., et al. Case-control association study of human netrin G1 gene in Japanese schizophrenia. J. Med. Dent. Sci. 2004, 51:121-128.
117. Ohtsuki T., et al. Association of polymorphisms in the haplotype block spanning the alternatively spliced exons of the NTNG1 gene at 1p13.3 with schizophrenia in Japanese populations. Neurosci. Lett. 2008, 435:194-197.
118. Bucan M., et al. Genome-wide analyses of exonic copy number variants in a family-based study point to novel autism susceptibility genes. PLoS Genet. 2009, 5:e1000536.
119. Sanders S.J., et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012, 485:237-241.
120. Arcos-Burgos M., et al. A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication. Mol. Psychiatry 2010, 15:1053-1066.
121. Jain M., et al. A cooperative interaction between LPHN3 and 11q doubles the risk for ADHD. Mol. Psychiatry 2012, 17:741-747.
122. Ribases M., et al. Contribution of LPHN3 to the genetic susceptibility to ADHD in adulthood: a replication study. Genes Brain Behav. 2011, 10:149-157.
123. Wang K., et al. Common genetic variants on 5p14.1 associate with autism spectrum disorders. Nature 2009, 459:528-533.
124. Mikhail F.M., et al. Clinically relevant single gene or intragenic deletions encompassing critical neurodevelopmental genes in patients with developmental delay, mental retardation, and/or autism spectrum disorders. Am. J. Med. Genet. A 2011, 155A:2386-2396.